Related Experiment Video
Updated: Jul 30, 2025

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury
Published on: February 21, 2025
Thrombin, a Key Driver of Pathological Inflammation in the Brain
Jaclyn Iannucci1, Paula Grammas2
1Department of Neuroscience and Experimental Therapeutics, School of Medicine, Texas A&M University, Bryan, TX 77807, USA.
Thrombin, a key inflammatory protein, drives neuroinflammation in Alzheimer's disease (AD) and other neurodegenerative conditions. Inhibiting thrombin may offer a therapeutic strategy to halt disease progression.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Neurodegenerative diseases, such as Alzheimer's disease (AD), are significant global health burdens.
- Neuroinflammation plays a critical role in the pathogenesis of these diseases.
- Elevated thrombin levels are observed in conditions associated with increased AD risk.
Purpose of the Study:
- To explore the role of thrombin as a key mediator of neuroinflammation in AD.
- To identify potential therapeutic targets for neurodegenerative diseases by understanding thrombin's inflammatory mechanisms.
Main Methods:
- Review of existing evidence on thrombin's role in AD and neuroinflammation.
- Analysis of studies investigating thrombin generation and its association with AD pathology in human and animal models.
Main Results:
- Thrombin, a coagulation cascade protein, is implicated in pathological events in AD and other neurodegenerative diseases.
- Coagulation factors, including thrombin, promote inflammation in the AD brain.
- Abnormal thrombin generation is linked to the promotion of AD pathology.
Conclusions:
- Thrombin drives neuroinflammation via activation of microglia, astrocytes, and endothelial cells.
- Inhibiting thrombin presents a potential therapeutic strategy for neurodegenerative diseases by interrupting inflammatory cascades.
- Thrombin is a promising therapeutic target for AD and related neurodegenerative disorders.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Inflammation
Clot Retraction and Fibrinolysis
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

